Life Science REIT (LABS) Competitors GBX 41 -0.90 (-2.15%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividend LABS vs. THRL, IHR, MXF, PHP, AGR, PRSR, ESP, HWG, SHED, and MLIShould you be buying Life Science REIT stock or one of its competitors? The main competitors of Life Science REIT include Target Healthcare REIT (THRL), Impact Healthcare REIT (IHR), Medicx Fund (MXF), Primary Health Properties (PHP), Assura (AGR), Prs Reit (PRSR), Empiric Student Property (ESP), Harworth Group (HWG), Urban Logistics REIT (SHED), and Industrials REIT (MLI). These companies are all part of the "real estate" sector. Life Science REIT vs. Target Healthcare REIT Impact Healthcare REIT Medicx Fund Primary Health Properties Assura Prs Reit Empiric Student Property Harworth Group Urban Logistics REIT Industrials REIT Life Science REIT (LON:LABS) and Target Healthcare REIT (LON:THRL) are both small-cap real estate companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, community ranking, risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends. Do insiders & institutionals believe in LABS or THRL? 67.3% of Life Science REIT shares are held by institutional investors. Comparatively, 69.4% of Target Healthcare REIT shares are held by institutional investors. 7.0% of Life Science REIT shares are held by company insiders. Comparatively, 0.1% of Target Healthcare REIT shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is LABS or THRL a better dividend stock? Life Science REIT pays an annual dividend of GBX 2 per share and has a dividend yield of 4.9%. Target Healthcare REIT pays an annual dividend of GBX 6 per share and has a dividend yield of 7.1%. Life Science REIT pays out -3,333.3% of its earnings in the form of a dividend. Target Healthcare REIT pays out 5,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Does the MarketBeat Community believe in LABS or THRL? Target Healthcare REIT received 89 more outperform votes than Life Science REIT when rated by MarketBeat users. However, 80.00% of users gave Life Science REIT an outperform vote while only 65.03% of users gave Target Healthcare REIT an outperform vote. CompanyUnderperformOutperformLife Science REITOutperform Votes480.00% Underperform Votes120.00% Target Healthcare REITOutperform Votes9365.03% Underperform Votes5034.97% Which has more risk & volatility, LABS or THRL? Life Science REIT has a beta of 0.08, indicating that its share price is 92% less volatile than the S&P 500. Comparatively, Target Healthcare REIT has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500. Which has preferable earnings and valuation, LABS or THRL? Target Healthcare REIT has higher revenue and earnings than Life Science REIT. Life Science REIT is trading at a lower price-to-earnings ratio than Target Healthcare REIT, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLife Science REIT£19.94M7.20-£21.71M-£0.06-683.33Target Healthcare REIT£69.55M7.49£73.02M£0.12700.00 Does the media favor LABS or THRL? In the previous week, Life Science REIT's average media sentiment score of 0.00 equaled Target Healthcare REIT'saverage media sentiment score. Company Overall Sentiment Life Science REIT Neutral Target Healthcare REIT Neutral Is LABS or THRL more profitable? Target Healthcare REIT has a net margin of 104.99% compared to Life Science REIT's net margin of -108.85%. Target Healthcare REIT's return on equity of 10.87% beat Life Science REIT's return on equity.Company Net Margins Return on Equity Return on Assets Life Science REIT-108.85% -7.20% 1.25% Target Healthcare REIT 104.99%10.87%3.86% Do analysts rate LABS or THRL? Life Science REIT currently has a consensus target price of GBX 46.50, suggesting a potential upside of 13.41%. Given Life Science REIT's stronger consensus rating and higher probable upside, analysts plainly believe Life Science REIT is more favorable than Target Healthcare REIT.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Life Science REIT 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Target Healthcare REIT 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryTarget Healthcare REIT beats Life Science REIT on 12 of the 18 factors compared between the two stocks. Ad Behind the MarketsUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?Click Here to learn how to get in now >>> Get Life Science REIT News Delivered to You Automatically Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LABS vs. The Competition Export to ExcelMetricLife Science REITREIT IndustryReal Estate SectorLON ExchangeMarket Cap£143.50M£1.30B£1.52B£1.62BDividend Yield6.21%7.41%6.44%6.83%P/E Ratio-683.33213.38276.161,753.00Price / Sales7.20525.28335.81249,198.64Price / CashN/A44.1462.6127.47Price / Book0.511.201.232.84Net Income-£21.71M-£53.40M-£46.51M£158.19M7 Day Performance-3.53%-1.62%-1.51%-0.63%1 Month Performance0.74%-2.09%-3.73%3.34%1 Year Performance-38.25%8.93%13.24%124.27% Life Science REIT Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LABSLife Science REITN/AGBX 41-2.1%GBX 46.50+13.4%-38.3%£143.50M£19.94M-683.33N/AGap UpTHRLTarget Healthcare REITN/AGBX 87.76+0.1%N/A+0.7%£544.31M£69.55M731.32N/AIHRImpact Healthcare REIT2.0659 of 5 starsGBX 87.30-1.1%N/A+0.6%£361.75M£53.51M793.64N/AMXFMedicx FundN/AGBX 96.40flatN/AN/A£0.00N/A0.00N/AHigh Trading VolumePHPPrimary Health Properties1.2468 of 5 starsGBX 95.85+0.3%N/A-2.8%£1.28B£177.80M-9,585.0058AGRAssura3.424 of 5 starsGBX 38.88-0.3%N/A-12.0%£1.26B£157.80M-3,888.0084News CoveragePRSRPrs ReitN/AGBX 107.02-0.7%N/A+25.7%£587.81M£53.68M972.912ESPEmpiric Student PropertyN/AGBX 91-0.3%N/A-3.5%£549.19M£81.60M1,011.11150Dividend AnnouncementInsider BuyingNews CoveragePositive NewsHWGHarworth GroupN/AGBX 169-0.6%N/A+53.2%£546.97M£95.50M1,126.67120SHEDUrban Logistics REIT2.1655 of 5 starsGBX 111.80+0.5%N/A-5.6%£527.67M£59.95M2,236.00N/ANews CoverageMLIIndustrials REITN/AGBX 168flatN/AN/A£494.79M£50.19M1,050.005,140 Related Companies and Tools Related Companies Target Healthcare REIT Alternatives Impact Healthcare REIT Alternatives Medicx Fund Alternatives Primary Health Properties Alternatives Assura Alternatives Prs Reit Alternatives Empiric Student Property Alternatives Harworth Group Alternatives Urban Logistics REIT Alternatives Industrials REIT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:LABS) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Life Science REIT plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Life Science REIT With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
